Triaminic

The United States Food and Drug Administration (FDA) plans to hold a public meeting on October 18, 2007, to discuss the safety of over-the-counter (OTC) children’s cough and cold medicines, including Triaminic. The meeting was not initiated by the FDA; rather, a group of doctors petitioned the agency to consider revising the labels.